Chiara Bottelli

1.6k total citations
24 papers, 685 citations indexed

About

Chiara Bottelli is a scholar working on Pathology and Forensic Medicine, Hematology and Genetics. According to data from OpenAlex, Chiara Bottelli has authored 24 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 12 papers in Hematology and 9 papers in Genetics. Recurrent topics in Chiara Bottelli's work include Lymphoma Diagnosis and Treatment (16 papers), Multiple Myeloma Research and Treatments (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Chiara Bottelli is often cited by papers focused on Lymphoma Diagnosis and Treatment (16 papers), Multiple Myeloma Research and Treatments (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Chiara Bottelli collaborates with scholars based in Italy, Ukraine and United States. Chiara Bottelli's co-authors include Alessandra Tucci, Giuseppe Rossi, Erika Borlenghi, Monica Drera, Samantha Ferrari, Caterina Stelitano, Michele Spina, Samantha Ferrari, Flavia Salvi and Maria Giuseppina Cabras and has published in prestigious journals such as Blood, Cancer and Clinical Cancer Research.

In The Last Decade

Chiara Bottelli

20 papers receiving 670 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Chiara Bottelli	410	307	182	171	154	24	685
Flavia Salvi	948 2.3×	477 1.6×	257 1.4×	62 0.4×	177 1.1×	50	1.2k
Isabella Capodanno	374 0.9×	203 0.7×	137 0.8×	26 0.2×	72 0.5×	22	611
Raffaella Marcheselli	304 0.7×	323 1.1×	108 0.6×	15 0.1×	160 1.0×	30	594
Benjamin M. Parsons	252 0.6×	204 0.7×	68 0.4×	16 0.1×	34 0.2×	36	440
José C. Díaz‐Maqueo	261 0.6×	294 1.0×	72 0.4×	9 0.1×	98 0.6×	34	529
Vittorio Ruggero Zilioli	156 0.4×	125 0.4×	112 0.6×	16 0.1×	57 0.4×	33	329
Jong Seok Lee	108 0.3×	215 0.7×	46 0.3×	37 0.2×	19 0.1×	18	478
Edna L. García	230 0.6×	287 0.9×	48 0.3×	9 0.1×	38 0.2×	29	473
Tzung‐Chih Tang	197 0.5×	146 0.5×	111 0.6×	8 0.0×	216 1.4×	33	507
Regina Gironés	49 0.1×	313 1.0×	21 0.1×	150 0.9×	21 0.1×	47	666

Countries citing papers authored by Chiara Bottelli

Since Specialization

Citations

This map shows the geographic impact of Chiara Bottelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Bottelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Bottelli more than expected).

Fields of papers citing papers by Chiara Bottelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Bottelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Bottelli. The network helps show where Chiara Bottelli may publish in the future.

Co-authorship network of co-authors of Chiara Bottelli

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Bottelli. A scholar is included among the top collaborators of Chiara Bottelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Bottelli. Chiara Bottelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Belotti, Angelo, Barbara Frittoli, Rossella Ribolla, et al.. (2025). Early identification of functional high-risk multiple myeloma patients after transplant: the predictive power of fat fraction and Response Assessment Category score in diffusion-weighted whole-body magnetic resonance imaging. Haematologica. 110(9). 2151–2159.

Belotti, Angelo, Barbara Frittoli, Rossella Ribolla, et al.. (2024). Early Identification of Functional High Risk Multiple Myeloma Patients after Transplant with Diffusion-Weighted Whole-Body MRI: Predictive Role of Fat Fraction in Addition to RAC Score. Blood. 144(Supplement 1). 82–82. 1 indexed citations

Borlenghi, Erika, Chiara Cattaneo, Diego Bertoli, et al.. (2022). Prognostic Relevance of NPM1 and FLT3 Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up—A Single Center Experience. Cancers. 14(19). 4716–4716. 4 indexed citations

Belotti, Angelo, Rossella Ribolla, Marco Chiarini, et al.. (2021). Sustained Residual Disease Negativity Assessed By Diffusion-Weighted Whole-Body MRI (DW-MRI) Has Strong Predictive Relevance for Survival in Newly Diagnosed Multiple Myeloma Patients on Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT). Blood. 138(Supplement 1). 1641–1641.

Schieppati, Francesca, Piera Balzarini, Simona Fisogni, et al.. (2019). An increase in MYC copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimens. Haematologica. 105(5). 1369–1378. 15 indexed citations

D’Adda, Mariella, Mirko Farina, Francesca Schieppati, et al.. (2019). The e13a2 BCR‐ABL transcript negatively affects sustained deep molecular response and the achievement of treatment‐free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors. Cancer. 125(10). 1674–1682. 46 indexed citations

D’Adda, Mariella, Mirko Farina, Francesca Schieppati, et al.. (2017). An e13a2 Type of BCR-ABL Transcript Has a Significant Adverse Impact on the Achievement of a Sustained Deep Molecular Response and on the Maintenance of a Treatment Free Remission after Stopping Tyrosine Kinase Inhibitors. Blood. 130. 1589–1589. 3 indexed citations

Stefoni, Vittorio, Beatrice Casadei, Chiara Bottelli, et al.. (2016). Short-course R-CHOP followed by 90Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results. Blood Cancer Journal. 6(5). e425–e425. 9 indexed citations

Arcaini, Luca, Lucia Morello, Alessandra Tucci, et al.. (2014). Autologous stem cell transplantation with in vivo purged progenitor cells shows long‐term efficacy in relapsed/refractory follicular lymphoma. American Journal of Hematology. 90(3). 230–234. 7 indexed citations

10.

Tucci, Alessandra, Maurizio Martelli, Luigi Rigacci, et al.. (2014). Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL). Leukemia & lymphoma. 56(4). 921–926. 118 indexed citations

11.

Rossi, Giuseppe, Luigi Marcheselli, Alessandra Dondi, et al.. (2014). The use of anthracycline at first‐line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi. American Journal of Hematology. 90(1). 56–61. 4 indexed citations

12.

Merli, Francesco, Stefano Luminari, Giuseppe Rossi, et al.. (2013). Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi. Leukemia & lymphoma. 55(1). 38–43. 56 indexed citations

13.

Chiappella, Annalisa, Alessandra Tucci, Alessia Castellino, et al.. (2013). Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi. Haematologica. 98(11). 1732–1738. 42 indexed citations

14.

Ponzoni, Maurilio, Pietro Luigi Poliani, William Vermi, et al.. (2011). Central nervous system marginal zone B-cell lymphoma associated with Chlamydophila psittaci infection. Human Pathology. 42(5). 738–742. 10 indexed citations

15.

Zaja, Francesco, Stefania De Luca, Umberto Vitolo, et al.. (2011). Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers. Haematologica. 97(3). 416–422. 52 indexed citations

16.

Zinzani, Pier Luigi, Giuseppe Rossi, Silvia Franceschetti, et al.. (2010). Phase II Trial of Short-Course R-Chop Followed by 90Y-Ibritumomab Tiuxetan in Previously Untreated High-Risk Elderly Diffuse Large B-Cell Lymphoma Patients. Clinical Cancer Research. 16(15). 3998–4004. 46 indexed citations

17.

Tucci, Alessandra, et al.. (2010). Association of Hodgkin Lymphoma and Non-Hodgkin Lymphoma In the Same Patient. Clinicopathologic Characteristics and Outcome In a Series of 20 Cases. Blood. 116(21). 3886–3886.

18.

Tucci, Alessandra, Samantha Ferrari, Chiara Bottelli, et al.. (2009). A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy. Cancer. 115(19). 4547–4553. 199 indexed citations

19.

Arcaini, Luca, Francesca Montanari, Emilio Paolo Alessandrino, et al.. (2008). Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma. Annals of Oncology. 19(7). 1331–1335. 25 indexed citations

20.

Tucci, Alessandra, Chiara Bottelli, Samantha Ferrari, et al.. (2007). A Comprehensive Geriatric Assessment Is More Effective Than Clinical Judgement to Prospectively Identify Elderly Patients with Diffuse Large Cell Lymphoma Who Can Tolerate Full-Dose Anthracyclin-Based Treatment and Achieve the Same Outcome as Young Patients.. Blood. 110(11). 3441–3441.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact